In contrast, PLIN2 deficiency suppresses SREBP activation, downregulating key lipid metabolic genes such as FASN and ACC, reducing hepatic accumulation of neutral lipids (TG and cholesterol), modulating membrane lipid fluidity, alleviating ER stress, and contributing to NAFLD prevention and mitigation [198]. This evidence concerns the gene FASN and metabolic dysfunction-associated steatotic liver disease.